Biopharma Data Champions Kickstarter

By 2022, 90% of corporate strategies will refer to data analytics. Data is becoming a core capability in addressing the challenges of increased cost pressures and regulatory requirements, new therapies and improving yields. Developing data literacy and skills will be vital to ensuring that biopharmaceutical organisations can transform large, complex, disconnected data sets into tangible business a…